POPULAR SECTIONS

TREATMENT REGIMENS DRUG INFO MEDICAL CALCULATORS PUBLISHERS ALLIANCE VIDEOS CME

VIEWPOINTS


Viewpoints is a collection of opinion articles written by thought leaders and expert medical writers to draw attention to important issues and developments in oncology.


CLEOPATRA Reveals New Treatment Option for HER2+ Breast Cancer Patients

CLEOPATRA Reveals New Treatment Option for HER2+ Breast Cancer Patients

Addition of pertuzumab to traztuzumab + docetaxel added almost 16 months to overall survival compared to those who didn't receive pertuzumab.

Does Regulatory Bureaucracy Drive Disparities in Cancer Drug Access Around the World?

Does Regulatory Bureaucracy Drive Disparities in Cancer Drug Access Around the World?

Regional disparities in cancer drug access have complex causes, including bureaucratic differences and variation in health care spending.

Cancer Treatment During Pregnancy Called Safe for Child

Cancer Treatment During Pregnancy Called Safe for Child

Case-control studies found no evidence of neurological or cardiac impairment in children exposed to chemotherapy or radiotherapy in utero.

Closed System Transfer Devices (CSTDs) for Chemotherapy: More Than an Added Layer of Protection

Closed System Transfer Devices (CSTDs) for Chemotherapy: More Than an Added Layer of Protection

While many facilities use some protective measures for chemo drugs, recent figures suggest that only 41% have adopted CSTDs.

Is Medical Marijuana Appropriate for Patients with Cancer?

Is Medical Marijuana Appropriate for Patients with Cancer?

With limited approval, a patchwork of state regulations regarding medical marijuana creates confusion among law enforcement and physicians alike.

Oncologists Encouraged to Speak Out on Regulatory Issues for Molecular Diagnostic

Oncologists Encouraged to Speak Out on Regulatory Issues for Molecular Diagnostic

Oncologists urged to speak out for increased regulation of laboratory-developed tests and uniformity among manufacturers in the U.S.

Combination Approach May Prevent Drug Resistance in Hematologic Malignancies

Combination Approach May Prevent Drug Resistance in Hematologic Malignancies

Using the right combination of drugs at a critical point in tumor evolution may stop the progression of heterogeneous tumors.

Sildenafil Use and the Risk of Melanoma

Sildenafil Use and the Risk of Melanoma

After approval and years of exposure in the general population, many medications have data analyses to identify unanticipated adverse events.

New ASCO/CCO Prostate Cancer Guidelines Emphasize Quality of Life

New ASCO/CCO Prostate Cancer Guidelines Emphasize Quality of Life

The right time for American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) on metastatic castration-resistant prostate cancer.

Certain Kind of Baldness at Age 45 Linked to Increased Risk of Prostate Cancer

Certain Kind of Baldness at Age 45 Linked to Increased Risk of Prostate Cancer

A recent study published in the Journal of Clinical Oncology links male pattern baldness with elevated risk of aggressive prostate cancer.

ALCHEMIST to Treat Early-Stage Lung Cancer With Erlotinib and Crizotinib

ALCHEMIST to Treat Early-Stage Lung Cancer With Erlotinib and Crizotinib

ALCHEMIST to screen 8,000 patients with early-stage lung cancer, randomly assigning patients with EGFR mutations or rearrangement of the ALK gene.

AACR Cancer Progress Report Urges Increased Congressional Funding for NCI and NIH Research Budgets

AACR Cancer Progress Report Urges Increased Congressional Funding for NCI and NIH Research Budgets

Newly released 2014 Cancer Progress Report from the American Association for Cancer Research highlights the need for increased federal funding of cancer research.

Genomic Research Indicates the Need for Cancer Reclassification

Genomic Research Indicates the Need for Cancer Reclassification

1 in 10 patients with cancer would be more accurately diagnosed if their tumors were defined by cellular and molecular criteria.

Breast Cancer Recurrence Reduced by NSAID Use in Overweight and Obese Women

Breast Cancer Recurrence Reduced by NSAID Use in Overweight and Obese Women

A retrospective study identifies a potential link between NSAID use and breast cancer recurrence and overweight and obese women.

Can Botox Block Gastric Cancer Growth?

Can Botox Block Gastric Cancer Growth?

More research is warranted to determine the effectiveness of Botox® (onabotulinumtoxinA) injections in slowing the growth of tumors.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs